Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009.       Akrimax president Alan L. Rubino commented, “This agreement further validates Akrimax’s decision to acquire the [Wyeth] Rouses Point facility, which possesses diverse manufacturing and packaging capabilities, and a spotless regulatory and safety record. We are pleased to announce this developmen...